Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era? Elisabeth V. GoessingerPhilippe GottfroisAlexander A. Navarini Leading Article Open access 11 September 2024 Pages: 861 - 872
Comparing Tretinoin to Other Topical Therapies in the Treatment of Skin Photoaging: A Systematic Review Zoya SiddiquiAlina ZufallMarian Russo Systematic Review 30 September 2024 Pages: 873 - 890
Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management Hemali ShahRose ParisiRoni P. Dodiuk-Gad Review Article Open access 15 September 2024 Pages: 891 - 908
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments Yanzhen PangWilliam Q. NguyenXiaolong A. Zhou Review Article 30 September 2024 Pages: 927 - 950
The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review Ai KuzumiAsako Yoshizaki-OgawaAyumi Yoshizaki Review Article Open access 05 October 2024 Pages: 951 - 966
A Practice Approach to Acne Fulminans in Adolescents Nicolas G. QuanRemie ChrabiehLucinda L. Kohn Therapy in Practice 13 September 2024 Pages: 967 - 974
Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata Xiaolin ZhangYiqun Jiang Therapy in Practice 03 September 2024 Pages: 975 - 986
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study Laurent MortierLisa VillabonaVanna Chiarion-Sileni Original Research Article Open access 08 October 2024 Pages: 987 - 996
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study Yu-Huei HuangSung Jen HungHsien-Yi Chiu Original Research Article 16 September 2024 Pages: 997 - 1008
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice Qi YinAlbert WolkerstorferPaul P. M. van Zuijlen Original Research Article Open access 19 September 2024 Pages: 1009 - 1017
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis Martim LuzTiago Torres Research Letter 27 September 2024 Pages: 1019 - 1021
Comment on “Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial” Lu-Ying WangYi-Hang DingChen Li Letter to the Editor 15 October 2024 Pages: 1023 - 1024
Authors’ Reply to Wang et al., “Comment on ‘Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial’” Yukari OkuboSatomi KobayashiTadashi Terui Letter to the Editor Open access 15 October 2024 Pages: 1025 - 1027
